Bromfed Dm
NDC Package 60432-837-15

11-digit billing NDC: 60432083715

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bromfed Dm is a . Marketed by Morton Grove Pharmaceuticals, Inc., this product is identified by NDC 60432-837 and is authorized under FDA application ANDA088811.

Identification & Billing

NDC Package Code
60432-837-15
Package Description
15 mL in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
60432083715

Clinical Specifications

Proprietary Name
Bromfed Dm
Dosage Form
-

Regulatory & Marketing

Labeler Name
Morton Grove Pharmaceuticals, Inc.
FDA Application #
ANDA088811
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-15-2010
End Marketing Date
06-30-2023
Listing Expiration
06-30-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (60432-837). Click a package code to view its specific billing and regulatory data.

118 mL in 1 BOTTLE, PLASTIC
473 mL in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60432-837-15 identifies a specific commercial package of 15 ml in 1 bottle, plastic of Bromfed Dm, labeled by Morton Grove Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Morton Grove Pharmaceuticals, Inc. on June 15, 2010. The current certification is valid through June 30, 2023.

How is this Morton Grove Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60432083715. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60432-837-15
11-Digit CMS (5-4-2)
60432-0837-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.